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ABSTRACT 27 
 28 
Contrast-enhanced ultrasound with sulphur hexafluoride microbubbles was performed in seven 29 
healthy dogs without a history of reproductive pathology and with histologically confirmed normal 30 
testes and in 42 dogs with chronic scrotal anomalies. All dogs underwent orchiectomy and 31 
histological examination. Enhancement patterns and perfusion parameters (peak intensity and 32 
regional blood flow) of testes of healthy dogs and testes with chronic lesions were compared. 33 
Fourteen non-pathologic and 60 pathologic testes were considered. Forty testes were neoplastic (24 34 
interstitial cell tumours, 9 seminomas, 7 Sertoli cell tumours), 20 were non-neoplastic (16 testicular 35 
degenerations, 2 chronic orchitis, 1 testicular atrophy, 1 interstitial cell hyperplasia). In healthy dogs 36 
the contrast medium flow had a rapid homogeneous wash-in and wash-out, with a short peak phase. 37 
With contrast ultrasound, testes that were inhomogeneous with a hyperenhancing pattern were 38 
associated with neoplasia (sensitivity: 87.5%, specificity: 100%). Lesions with persistent inner 39 
vessels and a hypo-to-isoechoic background were significantly associated with seminomas 40 
(sensitivity: 77.8%, specificity: 100%). Testes with non-neoplastic lesions were characterized by a 41 
scant/moderate homogeneous enhancement. Perfusion parameters were higher in neoplastic lesions. 42 
Contrast ultrasound was a feasible diagnostic tool in the assessment of testicular lesions, with 43 
hyperenhancement being an important feature in the diagnosis of malignancy. 44 
 45 
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INTRODUCTION 48 
 49 
Testicular disease is common in the dog and diagnostic B-mode ultrasound is frequently used for 50 
breeding soundness examination and also for the diagnosis of testicular abnormalities (England 51 
1991). Whilst B-mode ultrasound is useful for detecting parenchymal lesions as well as measuring 52 
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testicular volume (England 1991, England 1995), for many organ systems it has limited ability to 53 
differentiate malignant from benign disease; conditions which frequently have different 54 
vascularisation and might be differentiated using contrast-enhanced ultrasound assessment of 55 
vascular perfusion.  56 
In male dogs, testicular tumours are common, with an overall prevalence ranging between 6% and 57 
12%, second in frequency only to skin tumours, and have a higher incidence when compared to 58 
other species, including humans (Johnston et al 1991, Lawrence and Saba 2012). The most frequent 59 
testicular neoplasm is interstitial cell tumour, followed by seminoma and Sertoli cell tumour  60 
(Johnston et al 1991, Pugh and Konde 1991). Metastatic neoplasia affecting the testis is rare. Non-61 
neoplastic lesions are less common than neoplasia andbut include acute or chronic orchitis, 62 
epididymitis, testicular torsion, spermatocele, varicocele, hydrocele, sperm granuloma, testicular 63 
degeneration and atrophy (Johnston et al 1991, Pugh and Konde 1991).  64 
In men, ultrasonography is used extensively for the evaluation of intrascrotal lesions, and the most 65 
important goal of this diagnostic technique is the differentiation of malignant scrotal masses 66 
(Horstmann et al 1992, Lock et al 2011, Horstmann et al 1992, Bertolotto et al 2011, Valentino et al 67 
2011).  68 
In dogs, B-mode ultrasound and colour and power Doppler ultrasonography have been described 69 
for normal testes (Pugh and Konde 1990, Pugh and Konde 1991, Pugh and Konde 1990, Gunzel-70 
Apel et al 2001). There have been useful B-mode descriptions of testicular tumours and other 71 
scrotal abnormalities including hydrocele, testicular atrophy, inguinal hernia and infectious orchitis 72 
(Pugh and Konde 1991, England 1995, Pugh and Konde 1991, Ober et al 2004). Testicular 73 
neoplasms are described as lesions with different echogenicity, without a single characteristic 74 
ultrasonographic appearance (England 1995, Johnston et al 1991, Pugh and Konde 1991, England 75 
1995). Although no specific features have been reported associated with particular tumour types, 76 
three Sertoli cell tumours in undescended testes were reported to have a similar appearance, being 77 
hypoechoic with large anechoic areas (Pugh and Konde 1991).  78 
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Recently, contrast-enhanced ultrasound with second-generation contrast media has been introduced 79 
to clinical practice in human and veterinary medicine. The modern contrast agents are blood pool 80 
agents and do not leave the intravascular space. They comprise phospholipid-coated microbubbles 81 
containing gases of high molecular weight and low solubility in water, which provide better 82 
resistance to pressure and prolonged persistence in blood (Nyman et al 2005). The microbubbles 83 
have a non-linear response (rhythmic size changes of the bubble are not equivalent), when 84 
insonated with acoustic frequencies from 1 MHz to above 3 MHz and have low acoustic pressure 85 
(low Mechanical Index, MI). The non-linear response generates fundamental and harmonic 86 
components. The harmonic component strongly increases the backscattered signal, compared with 87 
the signal received from the bubbles in the fundamental frequency. Low MI imaging has the 88 
advantage of being minimally destructive to the bubbles and allows real-time imaging of the 89 
vascularity to the level of capillaries (O’Brien et al 2004). 90 
This new technology has proved to be a significant development for ultrasonographic examination 91 
because of the ability to image the microvasculature of tissues and organs in real time. Contrast 92 
ultrasound in dogs is particularly useful for the detection and characterisation of lesions of the liver, 93 
kidneys, spleen, and prostate gland (O’Brien et al 2004, Nyman et al 2005, Ohlerth et al 2007, 94 
Rossi et al 2008, Haers and Saunders 2009, Haers et al 2010, Nyman et al 2005,  O’Brien et al 95 
2004, Ohlerth et al 2007, Rossi et al 2008, Vignoli et al 2011). In humans there are few reports 96 
describing the use of contrast ultrasound in testesicular lesions, but it has been shown that the 97 
technique may facilitate detection of changes in testicular microcirculation in cases of varicocoele 98 
and segmental infarction Bertolotto et al 2011, Caretta et al 2010). Contrast ultrasound is more 99 
accurate than grey-scale and Doppler ultrasound for confirmation of diagnosis in acute scrotal 100 
disease, particularly infarction, trauma and torsion, as well as for detection of changes of 101 
microcirculation in cases of varicocele and for identifying testicular masses ((Caretta et al 2010, 102 
Bertolotto et al 2011, Valentino et al 2011, Lock et al 2011).  103 
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Commonly neoplastic testicular masses have increased vascularization and this feature may be 104 
important in the diagnosis of neoplasia (Lock et al 2011). 105 
To date there have been no studies assessing testicular perfusion with contrast ultrasound in dogs. 106 
The aim of this study was to describe the contrast-enhanced ultrasonographic features of chronic 107 
testicular lesions, and to evaluate whether contrast-ultrasound could provide useful information for 108 
differentiation of lesion type. 109 
 110 
MATERIALS AND METHODS 111 
 112 
The study was multicentric. Two groups of dogs were evaluated: a control group and a pathologic 113 
group. Cases of the control group were examined at the Department of Veterinary Clinical Science 114 
of the University of Naples. Inclusion criteria for the control group were: (1) clinically healthy male 115 
adult dogs, (2) no history of reproductive pathology, (3) absence of macroscopic, ultrasonographic, 116 
and microscopic lesions in the testes. Ethical approval for the study was given by the University of 117 
Naples.  118 
Cases of the pathologic group were examined at the Department of Veterinary Medical Science of 119 
the University of Parma and at the Private Practice Clinica Veterinaria dell’Orologio. Dogs were 120 
included if a focal or diffuse testicular lesion was detected by palpation and/or by ultrasound 121 
examination, further confirmed by histologic examination. Dogs with lesions in undescended testes 122 
were excluded from the study.  123 
Seven clinically healthy adult dogs that were to be castrated by owner’s request (age ranged 124 
between 2 and 4 years, body weight ranged between 6 and 37 kg), and 42 adult intact male dogs 125 
with scrotal anomalies (age ranged between 1.5 and 12 years and body weight between 5 and 45 kg) 126 
were enrolled in this multicentric study over a four-year period (2009-2012). Prior to the 127 
ultrasonographic evaluation, a complete general physical examination, serum chemistry profile and 128 
complete blood cell count were performed. Reproductive status was not evaluated. Informed 129 
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consent of the owners was obtained. All patients underwent grey-scale ultrasound of the scrotum 130 
with a 12 MHz linear transducer, prior to contrast ultrasound. Thoracic radiography and complete 131 
abdominal ultrasound (data not shown) was performed if there was a suspicion of neoplasia. All 132 
dogs were sedated with medtetdomidine (10 g/kg IM) and butorphanol (0.2 mg/kg IM) prior to 133 
contrast harmonic -ultrasound examination, in order to avoid patient movements and to achieve a 134 
better image quality.  135 
Contrast ultrasound equipment included two systems with coded harmonic capabilities (CnTI 136 
Esaote Megas Esatune®, Esaote, Genova, Italy and CnTI Mylab 30 Gold®, Esaote, Genova, Italy) 137 
and a linear probe with a receive frequency of 5 MHz. The mechanical index was always lower than 138 
0.15, which corresponded to an acoustic pressure lower than 45 kPa, to minimize microbubbles 139 
destruction. . A single focal zone was placed at the level of the mediastinum testis and the overall 140 
gain and time-gain compensation were set so that only a very low background signal from the 141 
testicular capsule and mediastinum testis was maintained to have an anatomical reference. All the 142 
testes were examined in the longitudinal plane. A bolus of 0.03 ml/kg of prepared solution (5 143 
mg/ml) of sulphur hexafluoride microbubbles (5 mg/ml, SonoVue®, Bracco, Milan, Italy) was 144 
injected in the cephalic vein, followed by a flush of 5 ml of saline solution. A timer was activated at 145 
the start of the injection and perfusion of a single testis was visualized in real time for at least 90 146 
seconds. The entire procedure was eventually repeated approximately 5 minutes later for evaluation 147 
of the contralateral testis. All dogs underwent orchiectomy, which was followed by histological 148 
examination performed at the Department of Veterinary Medical Science of the University of 149 
Parma.. The entire testes and epididymis were submitted to histology and standard colorations were 150 
performed. The reproductive status was not evaluated. 151 
 All the recorded videos were reviewed by one author (AV) and the enhancement patterns of the 152 
testes were subjectively described. The enhancement pattern was classified as homogeneous (no 153 
focal lesion detectable) or inhomogeneous (focal lesion detectable). If recorded as inhomogeneous, 154 
it was further classified as “hyperenhancing”, “isoenhancing”, “hypoenhancing”, by comparing the 155 
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brightness of the lesion to the surrounding testicular tissue after the injection of the contrast 156 
medium. A lesion was classified as hyperenhancing, if it was brighter than surrounding tissue either 157 
homogeneously or inhomogeneously or with rim enhancement or with prominent inner vessels. A 158 
lesion was considered isoenhancing when it was no more visible during contrast-ultrasound. A 159 
lesion was considered hypoenhancing when it was hypoechoic to the surrounding tissue.  160 
Quantitative analysis was performed to support qualitative analysis of the enhancement. Time-161 
intensity curves and colour-coded maps were reconstructed with a commercial software 162 
(QONTRAST®, Bracco, Milan, Italy), using the gamma variate bolus-corrected model. Peak 163 
intensity (PI, % of the sSignal iIntensity) and regional blood flow (RBF, the ratio between a value 164 
proportional to the area under the curve and the mean transit time) were considered. For 165 
inhomogeneous lesions, two regions of interest (ROI) were drawn, one including the area of the 166 
lesion and the other including surrounding tissue. Attention was paid to draw ROIs equal in 167 
dimension and in depth (Leinonen et al 2011).  168 
Enhancement patterns of neoplastic, non-neoplastic and non-pathologic testes were compared using 169 
Fisher’s exact test.  170 
For quantitative analysis, data were normally distributed (Shapiro-Wilk test). Perfusion parameters 171 
of inhomogeneous lesions were compared to the surrounding tissue with Student’s t test. Neoplastic 172 
lesions, non-neoplastic lesions and non-pathologic testes perfusion data were compared with 173 
ANOVA test, and subsequently with Games-Howell post-hoc test. Statistical data processing was 174 
performed using a commercial software package (Microsoft Excel version 97 SR-1: Microsoft 175 
Corporation, Redmond, Washington, USA) and WinPepi v. 11.28 (Abramson JH, WinPepi (PEPI-176 
for-Windows, freeware computer programs for epidemiologists. Epidemiologic Perspectives & 177 
Innovation 2004; 1:6. Freeware available from http://www.brixtonhealth.com/pepi4windows.html). 178 
Values were considered significant when P <0.05. 179 
 180 
RESULTS 181 
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 182 
The technique was reliably performed in all cases, yielding  images of good qualityconsistent 183 
results. No adverse effects were noted in any animal during the procedure. Serum chemistry profile 184 
and complete blood cell count were normal in all patients. 185 
No histopathological abnormalities were found in the 14 testes examine from the 7 healthy dogs. In 186 
these testes, subcapsular arteries, followed by intra-parenchymal arteries could be visualised during 187 
the wash-in phase (Fig 1-C). After a few seconds, a homogeneous moderate enhancement of the 188 
parenchyma was observed, with parenchymal vessels still distinguishable (Figure 1-D). After the 189 
peak phase, a rapid homogeneous decrease of echogenicity was detected. After 90 seconds only few 190 
microbubbles were visible in the testicular parenchyma.  191 
Sixty pathologic testes were consideredfound in the 42 dogs. Twenty-four patients had unilateral 192 
lesions, whilst 18 were bilateral. Among the 60 pathologic testes, 40 lesions were neoplastic (24 193 
interstitial cell tumours, 9 seminomas, 7 Sertoli cell tumours). The remaining 20 lesions were non-194 
neoplastic (16 testicular degenerations, 2 chronic necrotizing orchitis, 1 testicular atrophy, 1 195 
interstitial cell hyperplasia). No signs of metastasis were found outside of the testes in dogs with 196 
primary testicular neoplasia.  197 
Among the interstitial cell tumours, 111 were classified as solid and 13 as angiomatous. Solid 198 
interstitial cell tumours were either hypo or hyperechoic nodules when examined with B-mode 199 
ultrasound. Angiomatous interstitial cell tumours had a similar appearance but two cases showed up 200 
as cystic-like nodular lesions. With contrast-ultrasound, 21 of the testes with interstitial cell tumour 201 
were inhomogeneous, with the focal lesions showing an hyperehnhancing pattern (13 202 
homogeneous, 5 heterogenous, 3 with rim enhancement) and 3 were inhomogeneous with the focal 203 
lesions showing an hypoenhancing pattern (Figure 2).  204 
Among the seminomas, 7 were diffuse while 2 were intratubular type. With B-mode ultrasound 205 
diffuse seminomas were hypoechoic solid nodules with thin hyperechoic striations. The 206 
enhancement pattern of diffuse seminomas was peculiar; all of the testes were inhomogeneous with 207 
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the focal lesion showing an hypo-isoechoic background and several prominent inner vessels, which 208 
were still distinguishable in the wash-out phase (Figure 3). Intratubular seminomas were not 209 
detected with B-mode ultrasound. With contrast ultrasound the enhancement was homogeneous. 210 
Sertoli cell tumours were all histologically classified as solid type. They appeared as nodules with 211 
different echogenicity, in two cases they had hypoechoic cystic-like cavities. With contrast-212 
ultrasound, the testes with Sertoli cell tumour were all inhomogeneous with the focal lesions 213 
showing an hyperenhancing pattern (3 homogeneous, 3 heterogeneous and 1 with rim 214 
enhamcement) (Fig 4).  215 
Overall, neoplastic lesions were better visualized in the wash-in phase and tended to maintain the 216 
pattern during peak and wash-out.  217 
Degenerated testes had a normal or increased echogenicity, normal or reduced dimensions and in 218 
two cases several parenchymal hyperechoic foci were present, which histologically corresponded to 219 
small areas of fibrosis. Among the dogs with testicular degeneration, 4 dogs had bilateral 220 
involvement, whilst 5 had a tumour in the contralateral testis (4 interstitial cell tumours and one 221 
seminoma). Two dogs had monolateral involvement and one dog had interstitial cell hyperplasia in 222 
the contralateral testis. None of the dogs had signs of feminization. Testosterone/oestrogen blood 223 
levels however were not assayed. With contrast-ultrasound, all of the degenerated testes had 224 
homogeneous pattern with an enhancement subjectively lower than non-pathologic tissue.  225 
Testicular atrophy was manifest as a small testis that was inhomogeneous with B-mode in a dog 226 
with a contralateral sertolioma. With contrast ultrasound a very faint homogeneous enhancement 227 
was detected. 228 
The testes with chronic necrotizing orchitis were characterized by reduced dimensions and 229 
echogenicity. With contrast-ultrasound both of them had a scant homogeneous enhancement 230 
(Figure 5).  231 
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The interstitial cell hyperplasia appeared as an ill-defined small nodule, isoechoic to the 232 
surrounding parenchyma. With contrast-ultrasound, it was isoenhancing to the surrounding tissue 233 
and for this reason it was not visible.  234 
Overall, neoplastic lesions were better visualized in the wash-in phase and tended to maintain the 235 
pattern during peak and wash-out.  236 
Examination of the subjective findings to establish their diagnostic value showed that testes which 237 
were inhomogeneous with a hyperenhancing lesion were significantly associated with neoplasia 238 
(sensitivity: 87.5%, CI 95% 72.5-95.3%; specificity: 100%, CI 95% 87.3-100%; positive predictive 239 
value: 100% CI 95% 87.6-100%; negative predictive value: 87.1%, CI 95% 77.7-95.1%). Among 240 
the neoplasms, lesions that showed persistent inner vessels with a hypo-isoechoic background were 241 
significantly associated with seminomas (sensitivity: 77.8%, CI 95% 40.2-96%; specificity: 100%, 242 
CI 95% 86.2-100%; positive predictive value: 100% CI 95% 56-100%; negative predictive value 243 
93.9%, CI 95% 72.3-98.9%), while interstitial and Sertoli cell tumours showed a similar 244 
enhancement pattern.  245 
Perfusion parameters of neoplastic lesions and their surrounding tissue are presented in table 1. 246 
Perfusion parameters of non-pathologic tissue, neoplastic and non-neoplastic lesions are presented 247 
in table 2. PI and RBF were higher in neoplastic lesions when compared to the surrounding tissue 248 
(P<0.001). Comparing neoplastic lesions, non-neoplastic lesions and non-pathologic testes, there 249 
were statistically significant differences between group means, for both PI and RBF values, as 250 
determined by ANOVA test (P<0.001). Neoplastic lesions had a significantly higher PI and RBF 251 
than non-pathologic (P<0.05) and non-neoplastic testes (P<0.01). Non-neoplastic lesions had a 252 
lower PI and RBF than non-pathologic testes (P<0.05) and neoplastic lesions (P<0.01).  253 
 254 
DISCUSSION 255 
 256 
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Testicular tumours are frequent in dogs but there are relatively few reports of their ultrasonographic 257 
features (England 1995, Johnston et al 1991, Pugh and Konde 1991). In general there are no broad 258 
ultrasonographic features that appeared to be characteristic of a particular type of testicular lesion 259 
(Johnston et al 1991, Pugh and Konde 1991).  260 
To our knowledge, this is the first study to describe the ultrasonographic features of normal and 261 
chronic pathologic testes in dogs using contrast-enhanced ultrasound. This diagnostic technique can 262 
give more information on lesions and tissues vascularisation when compared to colour Doppler 263 
(Haers and Saunders 2009). This diagnostic technique is relatively easy to perform for a B-mode 264 
expert ultrasonographer, but because many factors influence the degree of contrast enhancement, 265 
such as different media, imaging units, injection protocol, dosage, mechanical index, site of the 266 
focal zone, a special attention must to be paid in setting the machine (O’Brien et al 2004). Although 267 
this was a multicentre study the same medium, dosage, injection protocol, imaging units, and the 268 
same setting of the machine were used, in order to minimize operator-dependent variability.  269 
Sulphur hexafluoride is a safe contrast agent, side effects described in humans and dogs are rare, 270 
usually minor, and include headache, nausea, pain at the injection site, altered taste, sensation of 271 
heat (humans) and vomiting (dogs) (Jackobsen et al 2005, Dolan et al 2009, Seiler et al 2013). 272 
Contraindications in humans include ischemic cardiomyopathy, severe pulmonary hypertension, 273 
severe systemic hypertension and right-to-left cardiac shunts (Jackobsen et al 2005). 274 
In the non-pathologic ormal testes the contrast medium flow had a rapid wash-in and wash-out, 275 
with a short peak phase and a moderate enhancement. The enhancement pattern was differentThe 276 
differences to other organs such as liver and spleen and may relate to the smaller total blood volume 277 
of the testis, compared with the liver and spleen and to differences of the blood supply and vascular 278 
anatomy (Lock et al 2011). The liver is supplied by a dual system, hepatic artery and portal vein, 279 
and hepatic and splenic microcirculation is characterized by the presence of large sinusoids,  in 280 
which the transit of microbubbles is very slow, resulting in a persistent enhancement (Nyman et al 281 
2005, Ohlerth et al 2007). In the testes the flow of microbubbles is rapid, since no sinusoids are 282 
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present in their parenchyma. In fact, tTestes are supplied by testicular arteries, which are branches 283 
of the abdominal aorta and enter the tunica albuginea to form capsular arteries. The capsular arteries 284 
have centripetal branches that enter the parenchyma and flow toward the mediastinum. As they 285 
approach the mediastinum, they arborize into recurrent rami that branch back in the opposite 286 
direction. The veins exit the mediastinum and empty into the pampiniform plexus, which drains into 287 
the ispsilateral testicular veins (Horstmann et al 1992).  288 
 289 
A limitation of the present study was that the reproductive status of the animals included in the 290 
healthy group has not been evaluated. Further studies are needed on normal dogs with a 291 
documented reproductive status in order to better characterise the perfusion pattern of normal testes 292 
with contrast ultrasound. Another limitation was that dogs were sedated. It is important to recognise 293 
that vascular status can affect perfusion dynamics, and comparisons of perfusion parameters can 294 
only be made for animals subject to the same sedative or anaesthetic regimen. Recently, alpha 2-295 
adrenergic agonist   dexmedetomidine, similar to medetomidine used in this study, has been proved 296 
to reduce organ blood flow in dogs and therefore to influence perfusion parameters of contrast-297 
enhanced ultrasound. Peak intensity was lower in kidneys in dogs sedated with dexmedetomidine. 298 
Arrival time and time to peak were significantly higher in liver, spleen, kidneys and intestine in 299 
dogs sedated with dexmedetomidine (Restitutti et al 2013). Further studies on testicular contrast 300 
ultrasound are needed in dogs with different sedation protocols, as well as in conscious non-sedated 301 
dogs, including a larger number of subjects. 302 
  Testicular tumours are frequent in dogs but there are relatively few reports of their 303 
ultrasonographic features (Johnston et al 1991, Pugh and Konde 1991, England 1995). In general, 304 
there are no reported ultrasonographic features that appeared to be characteristic of a particular type 305 
of testicular lesion, when B-mode ultrasound is considered (Johnston et al 1991, Pugh and Konde 306 
1991). 307 
 308 
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In humans, testicular tumours are generally described as being hypervascular with colour Doppler, 309 
but this feature can also be identified in cases of acute orchitis (Horstmann et al 1992). Recent 310 
reports have described the use of contrast-enhanced ultrasonography of the human testes (Caretta et 311 
al 2010, Bertolotto et al 2011, Valentino et al 2011, Hedayati et al 2012, Caretta et al 2010). 312 
Contrast ultrasound was thought to be useful in assisting the diagnosis of testicular masses, and in 313 
cases of acute scrotal pain, varicocele, testicular trauma and acute segmental infarction (Bertolotto 314 
et al 2011, Valentino et al 2011, Caretta et al 2010, Hedayati et al 2012) . In a further study, hyper-315 
enhancement in the early wash-in phase showed a sensitivity of 88.4% and a positive predictive 316 
value of 97.4% for neoplastic testicular lesions (Lock et al 2011). In the cases of neoplasia, contrast 317 
ultrasound demonstrated a slight or strong enhancement of the lesion in the early wash-in, which 318 
became hypoechoic later in the wash-out phase, with a sensitivity of 88.4% and a positive 319 
predictive value of 97.4% (Lock et al 2011).  320 
In the present study, most testicular tumours were hyperenhancing to the surrounding tissue, when 321 
examined with contrast ultrasound. Contrary to contrast dynamics observed in the liver, there was 322 
no specific phase associated with different patterns of lesional contrast-enhancement over time. 323 
Thus a lesion with early hyper-enhancement tended to maintain that pattern during the entire 324 
examination, but best visualization was provided during the wash-in, similarly to humans (Lock et 325 
al 2011, Valentino et al 2011). Hyperenhancement was either homogeneous, with rim enhancement, 326 
or with prominent inner vessels and had a sensitivity of 87.5% and a positive predictive value of 327 
100% for neoplasia, similar to values found in the human literature (Lock et al 2011, Valentino et al 328 
2011). In this study, prominent and persistent inner vessels within a hypoechoic background lesion 329 
were peculiar features of diffuse seminomas, which are not reported in humans. Human seminomas 330 
are described as hyper-enhanced focal lesions with rapid wash-out and are not distinguishable from 331 
other solid neoplasms (Lock et al 2011, Valentino et al 2011). The reason forof this difference in 332 
findings between species is unknown, although there is a correspondence in the description of grey-333 
scale ultrasonographic features (Caldwell et al 1980, Lock et al 2011, Caldwell et al 1980). 334 
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Interestingly, intratubular-type seminomas could not be imaged with contrast ultrasound, due to 335 
their very small dimensions, and this could represent a limitation of this diagnostic technique. 336 
However, a larger number of seminomas would be needed to further assess and confirm theseeir 337 
particular ultrasonographic features. Interstitial cell and Sertoli cell tumours could not be 338 
differentiated with contrast ultrasound since most of them appeared as hyper-enhanced lesions, 339 
which were well visualized in the early wash-in phase. 340 
It is known that testicular cytology is a powerful and minimally invasive diagnostic tool to assess 341 
testicular pathology (Dahlbom et al 1997, Santos et al 2010). Another advantage of cContrast 342 
ultrasound is tomay support testicular cytology/histology by indicating the proper sampling site, if a 343 
fine-needle-aspiration or a biopsy is requested . The definition of enhancing and subsequently of 344 
viable tumour regions is better characterized with contrast-ultrasound, resulting in increased 345 
accuracy of percutaneous biopsy (Gelb et al 2010, Sparchez et al 2011).and allowing avoiding 346 
hypovascular/necrotic tissue.  347 
Most of benign lesions such as testicular degeneration or atrophy and chronic orchitis appeared as 348 
diffuse lesions, homogeneously hypo-enhancing when compared to non-pathologic testes. In men, 349 
benign lesions such as necrosis, atrophy, ectasia of rete testis, hematoma, epidermoid cysts and 350 
torsion are described as hypo- or non-enhancing lesions (Lock et al 2011, Valentino et al 2011, 351 
Patel et al 2012). Testicular degeneration and atrophy is commonly described in dogs as a change 352 
secondary to testicular neoplasia in the contralateral testis where it is caused by an excess of sexual 353 
hormones secreted by the tumour, but it is also recognised as an age-related change (Peters and van 354 
Slujis 1996). 355 
The descriptive assessments of testicular enhancement pattern for different lesion types were 356 
confirmed by quantitative perfusion analysis, which may help to better visualize the lesion 357 
vascularization, especially when the colour-coded maps are considered. 358 
In conclusion, contrast ultrasound appears to be a feasible diagnostic tool in the assessment of 359 
testicular perfusion in the dog and in particular may allow the documentation of focal testicular 360 
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lesions, with some limitations due to the cost of contrast medium, the need for dedicated ultrasound 361 
equipment and time required to perform the examination.. This technology, using second-362 
generation contrast medium, may provide an additional tool to facilitate in vivo classification of 363 
testicular lesions. Finally, hypervascularisation appears to be an important feature in the diagnosis 364 
of malignancy. 365 
 366 
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